Position in TGTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$16,797,692
+$789,157 QoQ
Shares Held
505,650
-5.8% QoQ
Ownership
0.330%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$209,286
PutShares
6,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. TGTX ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in TGTX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,797,692 | 505,650 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $209,286 | 6,300 | Put | Defined | 2026-05-05 | |
| 2025-12-31 | $190,784 | 6,400 | Put | Defined | 2026-01-29 | |
| 2025-12-31 | $16,008,535 | 537,019 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $22,333,486 | 618,228 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $289,000 | 8,000 | Put | Defined | 2025-11-13 | |
| 2025-06-30 | $19,126,558 | 531,441 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $287,920 | 8,000 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $5,196,956 | 144,400 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $24,907,574 | 631,691 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,477,617 | 647,097 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,576,684 | 665,955 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,254,924 | 520,232 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,979,498 | 524,622 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $9,647,398 | 564,836 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,972,523 | 355,565 | Shares | Defined | 2023-11-09 | |
| 2023-09-30 | $147,972 | 17,700 | Put | Defined | 2023-11-09 | |
| 2023-06-30 | $3,611,536 | 145,392 | Shares | Defined | 2023-08-11 | |
| 2023-06-30 | $911,628 | 36,700 | Put | Defined | 2023-08-11 | |
| 2023-03-31 | $4,013,875 | 266,880 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,391,721 | 455,767 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $130,150 | 21,985 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $575,240 | 135,351 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,463,806 | 153,923 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,822,048 | 253,792 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,705,363 | 81,291 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $244,260 | 6,297 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,294,320 | 47,600 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $414,599 | 7,970 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $228,771 | 8,549 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $125,197 | 6,427 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $667,967 | 67,883 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||